Erasca ERAS Insider Ownership

NASDAQ ERAS
$16.27 +0.01 (+0.06%)
As of: Sep 4, 2026 · 11:49 AM EDT

Insider Holdings by Owner

12.29Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.0071%
0% pp QoQ
Shares Held by Insiders
20.00K
filed for Sep 2026
0.00% QoQ
Shares Outstanding
283.68Mn
283,681,570 shares
Direct Holdings
0
Indirect: 20.00K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
7
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of August 29, 2026, Erasca's top three insider holders are Venture Partners X, Llc Arch (TenPercentOwner, 11.06Mn shares), Alexander W. Casdin (Director, 573.97K shares), Lin Wei (Chief Medical Officer, 315.81K shares).

Form 4 Holdings

Insiders Holding ERAS

Insiders 7
Shares held 12.29Mn
Of outstanding 4.33%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Venture Partners X, Llc Arch TenPercentOwner 0 11,055,554 11,055,554 90.0% 20 Jul, 2021
2 Alexander W. Casdin Director 573,974 0 573,974 4.7% 22 May, 2024
3 Lin Wei Chief Medical Officer 315,812 0 315,812 2.6% 02 Feb, 2023
4 David M. Chacko Cfo And Cbo 279,980 0 279,980 2.3% 30 Jan, 2026
5 Ebun Garner Chief Legal Officer 25,076 0 25,076 0.2% 03 Apr, 2026
6 James Arthur Bristol Director 0 20,000 20,000 0.2% 22 Dec, 2022
7 Valerie Denise Harding Start Director 0 20,000 20,000 0.2% 07 Dec, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

271 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
10 Aug, 2026 Charles S. Fuchs President, Rd Acquired A 1,300,000 $0.00 $0 1,300,000 Direct
26 Jun, 2026 Valerie Denise Harding Start Director Acquired A 29,888 $0.00 $0 29,888 Direct
26 Jun, 2026 Alexander W. Casdin Director Acquired A 29,888 $0.00 $0 29,888 Direct
26 Jun, 2026 Julie Hambleton Director Acquired A 29,888 $0.00 $0 29,888 Direct
26 Jun, 2026 Jean I Liu Director Acquired A 29,888 $0.00 $0 29,888 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Acquired M 80,000 $1.70 $136.00K 105,076 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Acquired M 80,000 $1.70 $136.00K 105,076 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Acquired M 80,000 $1.70 $136.00K 105,076 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Acquired M 80,000 $1.70 $136.00K 105,076 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Disposed S 80,000 $16.40 $1.31Mn 25,076 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Disposed S 80,000 $16.40 $1.31Mn 25,076 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Disposed S 80,000 $16.40 $1.31Mn 25,076 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Disposed S 80,000 $16.40 $1.31Mn 25,076 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Disposed M 80,000 $0.00 $0 280,000 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Disposed M 80,000 $0.00 $0 280,000 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Disposed M 80,000 $0.00 $0 280,000 Direct
01 Apr, 2026 Ebun Garner Chief Legal Officer Disposed M 80,000 $0.00 $0 280,000 Direct
04 Mar, 2026 Shannon Morris Chief Medical Officer Acquired M 20,000 $1.70 $34.00K 20,000 Direct
04 Mar, 2026 Shannon Morris Chief Medical Officer Acquired M 20,000 $1.70 $34.00K 20,000 Direct
04 Mar, 2026 Shannon Morris Chief Medical Officer Acquired M 20,000 $1.70 $34.00K 20,000 Direct